Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS
Content archived on 2024-05-27

Enhancement of nasal vaccination - improved immune protection, safety and cost-effectivness through optimisation of mucosal and nasal delivery system.

Objective

Nasal administration of vaccines provides superior immune protection and is more convenient and cost-effective compared to injection. Development of new well-tolerated adjuvant is required to enhance the immunological response and expand the application of vaccines administered via mussel surfaces. Furthermore, the currently used nasal delivery systems cannot provide adequate dose distribution, reproducibility and dose uniformity to fully exploit the potentials of nasal mussel vaccines. Eurocent AB (Sweden) has developed an adjuvant for nasal vaccines, which compared to currently used adjuvant, provides significantly improved immune response. Optimise AS (Norway) offers a patent pending user-friendly, efficient and safe delivery of nasal vaccines (powders/liquids, mono-/multimode), which is optimal for mass vaccination. Our objective is to develop an improved and cost effective system for nasal vaccination, providing superior immune protection, safety and user friendliness.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

Data not available

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

EAW - Exploratory awards

Coordinator

EUROCINE AB
EU contribution
No data
Address
Karolinska Institute Science Park, Foqdevreten 2
171 77 STOCKHOLM
Sweden

See on map

Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data

Participants (1)

My booklet 0 0